CCL Products (India) (CCL) Q2 24/25 earnings summary

Executive summary

• Achieved Q2 FY25 consolidated turnover of INR 738.2 crores (₹73,819.77 lakhs), up 21.5% year-over-year; net profit at INR 73.95 crores (₹7,395.39 lakhs), also up 21.5% year-over-year.

• H1 FY25 turnover reached INR 1,511.49 crores, a 20% increase; net profit for H1 at INR 145.4 crores, up 19.6% year-over-year.

• Domestic business showed strong momentum, with gross turnover of INR 200 crores in H1 and branded sales of INR 135 crores.

• Standalone revenue for Q2 FY25 was ₹43,690.32 lakhs, up from ₹35,195.44 lakhs in Q2 FY24; standalone net profit was ₹2,762.48 lakhs.

Financial highlights

• EBITDA for Q2 FY25 at INR 137.6 crores, up 24.3% year-over-year; H1 EBITDA at INR 269.2 crores, up 24%.

• Consolidated EBITDA for H1 FY25 was ₹23,570.82 lakhs, up from ₹13,912.52 lakhs in H1 FY24.

• Basic EPS (consolidated) for Q2 FY25 was ₹5.55, up from ₹4.57 in Q2 FY24.

• Volume growth for the quarter was close to 10%, with EBITDA growth driven by both volume and better margin business.

• Branded business value growth nearly 50% in H1.

Outlook and guidance

• Maintains volume growth guidance of 10-20% for FY25 due to volatility in green coffee prices and short-term contracts.

• No new CapEx planned for next 3-4 years; current capacity sufficient.

• Vietnam FDC line expected to commercialize after current quarter's trials.

• Branded business expected to close FY25 at around INR 300 crores.

• Board and auditors reviewed and approved the unaudited results, with no modifications in the audit report.